L. S. Banitt

Discovery and Characterization of QPT-1, the Progenitor of a New Class of Bacterial Topoisomerase Inhibitors

G. Bammert, A. Hromockyj, K. Marotti, 2008, Antimicrobial Agents and Chemotherapy.

Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.

K D Watenpaugh, W. Howe, D. Anderson, 1997, Journal of medicinal chemistry.

Novel oxazolidinone-quinolone hybrid antimicrobials.

J. Gage, C. Parker, D. Patel, 2003, Bioorganic & medicinal chemistry letters.

Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity.

E. Hall, D. Ayer, J. Chin, 1995, Journal of medicinal chemistry.

Preclinical evaluation of anti-inflammatory activities of the novel pyrrolopyrimidine PNU-142731A, a potential treatment for asthma.

J. Chin, G. Winterrowd, R. Krzesicki, 1999, The Journal of pharmacology and experimental therapeutics.

Synthesis of 2,4-Di-1-pyrrolidinyl-9H-pyrimido[4,5-b]indoles, Including Antiasthma Clinical Candidate PNU-142731A

J. Palmer, G. Bundy, T. Schwartz, 2001 .

Stereoselective synthesis of [11 β‐3H]prostaglandin E1

G. Bundy, J. Easter, R. Hsi, 1993 .

Discovery and Characterization of QPT-1, the Progenitor of a New Class of Bacterial Topoisomerase Inhibitors (cid:1) †

G. Bammert, A. Hromockyj, K. Marotti, 2008 .

Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.

Thomas J. Raub, E. Hall, D. Ayer, 1996, Acta neurochirurgica. Supplement.